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Elizabeth Sharpe*
I. Introduction
Imagine being able to treat Type 2 diabetes without pharmaceuticals and, instead,
providing patients with chronic health conditions access to food that can be used to treat the
condition.1 Food insecurity, defined as a lack of access to adequate food, is negatively associated
with health.2 Chronic diseases disparately impact minority and low-income populations, creating
a cycle of continued food insecurity and increasingly poor health outcomes.3 Chronic health
conditions that can be addressed, mitigated, or controlled through an individual’s diet include
diabetes, HIV/AIDS, and cancer.4
The “food-as-medicine” movement attempts to improve the health outcomes of chronically
ill patients while simultaneously addressing issues of food insecurity. Food insecurity is associated
with many of the costliest health conditions, including congestive heart failure, obesity, diabetes,
and depression.5 Nearly one in three adults with a chronic health condition have problems paying
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for food, medicine, or both.6 A 2016 report estimated the annual direct and indirect health costs
of food insecurity in the United States at $160 billion.7
The utilization of food-as-medicine typically requires a healthcare provider to “prescribe”
a particular diet to address a diagnosed health condition.8 In some models, after a patient has
received a prescription, the patient receives food at no or reduced cost through a “dispenser.” 9
Independent businesses, hospital-sponsored “farmacies,” and non-profit organizations serve as
dispensers.

These dispensers can provide food in various forms and at various levels of

convenience.
The food-as-medicine movement is largely unregulated beyond the local rules that apply
to all food businesses.10

Given the unique challenges of utilizing food as medicine for the

treatment of chronic health conditions, the United States should implement a more expansive and
effective regulatory system. As this Comment argues, a cohesive, comprehensive regulatory
scheme will allow the continued implementation of food-as-medicine.
The United States Food and Drug Administration (FDA) is equipped to manage the
complicated regulation of the food-as-medicine movement and should be tasked with developing
the first comprehensive regulatory scheme. To date, there is no national regulation of the food -as-
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9 See Alice Park, Why Food Could Be the Best Medicine of All, TIME (Feb. 21, 2019), https://time.com/longform/foodbest-medicine/.
10 See, e.g., The Food is Medicine Coalition Applauds the Introduction of The Medically Tailored Home -Delivered
Meal Demonstration Pilot Act of 2020 (H.R. 6774) (Aug. 12, 2020) (“[O]ur federal policies are behind the science on
this.”); see also Robert Greenwald, Food As Medicine: The Case for Insurance Coverage for Medically-Tailored Food
Under the Affordable Care Act (2015) (“We need stronger regulations . . . to promote effective insurance coverage,
reduce discriminatory practices, and ensure that vulnerable populations are served.”).
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medicine movement, though state-level initiatives exist.11 Following FDA’s development and
implementation of such a scheme, other regulatory agencies must regulate the food-as-medicine
movement to encourage its adoption.
This Comment provides an overview of the current state of the food -as-medicine
movement and proposes a regulatory scheme to encourage food-as-medicine utilization and
growth. Section II of this Comment introduces existing food-as-medicine dispensing models and
details their successes. Section III evaluates the challenges that are faced by the food-as-medicine
movement due to lack of regulation. Section IV identifies existing FDA regulatory schemes that
may provide a framework for regulating the food-as-medicine movement. Section V proposes an
FDA food-as-medicine regulatory scheme that addresses both the short-term and long-term needs
for effective regulation.
II. Food-As-Medicine Dispensing Models
Three primary dispensing models currently exist within the food-as-medicine movement.
Each model may dispense one or more forms of food. Dispensers may take the form of (1) ecommerce businesses, (2) healthcare provider-sponsored dispensaries, or (3) non-profit
distributors. Each dispensing model can distribute food at various stages of convenience and
preparedness. Food can be distributed ready-to-eat, ready-to-prepare, or as whole foods that
require full preparation by the recipient.
While each dispensing model and each food type can create demonstrable health impacts,
providers must “meet” the patient where the patient currently is. For many patients, fully prepared
meals are likely the most appealing and best suited to their lifestyle. To motivate meaningful
change and reduce reliance on fully prepared meals, patients should be transitioned down the
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convenience spectrum (from fully prepared meals to whole foods that can be prepared into a meal)
over time. Studies demonstrate that meal kits are effective at changing food decision behavior
because individuals select healthier options when a meal kit is provided along with a recipe.12
Many patients will need nutrition education and kitchen skills training to realize long-term,
sustainable effects.13
A. Food Types
Three main food types exist within the food -as-medicine movement, along a scale of
convenience for the patient. First, dispensers may provide fully prepared meals that only require
reheating to be consumed.14 These are “medically tailored meals,” which are designed specifically
to address certain diet needs.15 These medically tailored meals seek to provide convenience to
patients while targeting the individual’s chronic health conditions. 16
Second, dispensers may provide meal components and a recipe or meal plan for the patient
to follow.17 Typically, these meal kits are supplemented with nutrition education. 18 Although not
as convenient as medically tailored meals, these dispensing models require less food handling than
prepared meals and still provide guidance for the patient.
Lastly, dispensers may provide the components of a healthy diet without direction or
specific tailoring of the product offered.19 This model is typically in the form of a “prod uce
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Blue Apron-Inspired Meal Kits Spur Healthy Selections, FOOD BANK NEWS (May 2, 2019),
https://foodbanknews.org/blue-apron-inspired-meal-kits-prompt-healthy-food-selection-at-pantry/.
13 Though outside the scope of this Comment, nutrition education has been shown to improve dietary habits and health
outcomes. See, e.g., Pei Lin Lua & Wan Dali Wan Putri Elena, The Impact of Nutrition Education Interventions on
the Dietary Habits of College Students in Developed Nations: A Brief Review, 19 M ALAYS. J. M ED. SCI. 4 (2012),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436500/ (finding significant changes in dietary habits among
college students after nutrition education).
14 The Medically Tailored Meal Intervention, FOOD IS M EDICINE C OALITION, http://www.fimcoalition.org/our-model.
15 Id.
16 While these medically tailored meals are not custom -made for a particular patient, meal plans can typically be
combined to address a particular patient’s specific medical needs.
17 Hess, Passaretti & Coolbaugh, supra note 1, at 830.
18 Id.
19 Bryce et al., Participation in a Farmers’ Market Fruit and Vegetable Prescription Program at a Federally Qualified
Health Center Improves Hemoglobin A1C in Low Income Uncontrolled Diabe tics, PREVENTIVE M ED. REPORTS 7, 176
(2017).
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prescription,” where the patient receives either money to purchase produce at a grocery store or
farmers’ market or a collection of produce and other staple items from the dispenser.20 While this
model is the least convenient for the patient, it provides the most flexibility for the patient and
reduces the dispenser’s involvement.
B. Dispensing Models
Three primary entity types dispense food-as-medicine programs: (i) e-commerce
businesses, (ii) healthcare provider-sponsored dispensaries, and (iii) non-profit organizations. In
the e-commerce dispensing model, an independent company takes referrals from physicians or
insurers for medically tailored meals or other foods. 21 The company then provides the prescribed
food to the patient, typically via shipping services. These companies are operated independently
from the patient’s prescriber or healthcare organization.
At times, a healthcare provider may sponsor a dispensary of food for its patients. Hospitals
typically sponsor such programs, although insurers may also do so. In this model, the patient will
generally receive the food prescribed at discharge from a hospital or during recurring visits with a
healthcare provider.22
Finally, non-profit organizations or state and local agencies may sponsor a food -asmedicine program.

These programs often are similar to Meals-on-Wheels or food pantry

arrangements with the caveat that the foods provided are designed and designated for those with
chronic health conditions who have been prescribed the diet provided by the program. 23
C. Case Studies: Existing Dispensing Businesses
1. Community Servings (Massachusetts)

20

Id.
See About, Mom’s Meals, momsmeals.com/about/ (last visited Apr. 29, 2021).
22 Park, supra note 9.
23 Cohn & Waters, supra note 4.
21
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Community Servings was founded in 1990 as an organization to provide home-delivered
meals to individuals living with HIV/AIDS. 24 The organization has since expanded to serving
individuals with any critical or chronic illness. 25 Community Servings is a non-profit organization
dedicated to providing free, culturally relevant home-delivered meals and nutrition education to
those with acute, life-threatening illnesses, their dependents/children, and their caregivers.26 It
offers medically tailored meals, nutrition education and counseling, and food service job training.27
The meals served are made from scratch and are customized to meet the nutritional and medical
needs of the client.28 Community Servings offers fifteen different medical diets, and allows clients
to choose up to three of those diets to be combined for their meal. 29 To be eligible for the service,
clients must complete an intake packet and submit a medical certification form from their doctor
or nurse.30
Community Servings has served over nine million meals since its inception. 31 The program
costs approximately $1200 per patient per year. 32 As one study found, however, the program
results in a net reduction in annual costs because it saves clients approximately $500 a month in
medical expenses.33
2. Geisinger Health System Fresh Food Pharmacy (Pennsylvania)
Geisinger Health System is an integrated health services organization that identified a need
for affordable, nutritious foods within its patient population.34 Geisinger launched a Fresh Food

24

History, Community Servings, https://www.servings.org/history/ (last visited Apr. 29, 2021).
Id.
26 Cohn & Waters, supra note 4.
27 About Us, Community Servings, https://www.servings.org/about-us/ (last visited Apr. 29, 2021).
28 Meal Delivery, Community Servings, https://www.servings.org/meal-delivery (last visited Apr. 29, 2021)/.
29 Id.
30 Id.
31 History, Community Servings, https://www.servings.org/history/ (last visited Apr. 29, 2021).
32 Cohn & Waters, supra note 4.
33 Seth Berkowitz & David B. Waters, The Impact of Medically Tailored Meals, Community Servings, June 2018,
https://www.servings.org/wp-content/uploads/2018/06/MTM_Community-Servings-Final_Web-Friendly.pdf.
34 An Rx for Good Health: Geisinger Launches Fresh Food Pharmacy, Geisinger Health System (2016).
25
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Pharmacy in partnership with the Central Pennsylvania Food Bank. 35 The Pharmacy provides
patients weekly groceries, recipes and menus, and recurring interactions with health managers.36
The Pharmacy also offers free educational programs on nutrition and health management. 37
The program has demonstrated significant improvements in patient health.

Tom

Sincowich, a Fresh Food Pharmacy patient, has Type 2 diabetes.38 During his first year in the
program, Sincowich lost forty-five pounds, reduced his reliance on diabetes medications, and
lowered his blood sugar and blood pressure levels.39 Notably, Sincowich reduced his A1C level,
which is used to diagnose diabetes, from approximately eleven to the high six range level.40 An
A1C level of 6.5 is used as the threshold determination for Type 2 diabetes.41
Geisinger’s Fresh Food Pharmacy spends about $1,000 annually on each Pharmacy
patient.42 Early estimates indicate that the annual savings per patient could be close to $24,000
when the program changes key health indicators, as occurred in Sincowich’s case.43 All patients
in the program are low-income, so the provision of food through the Pharmacy is particularly
impactful.44 The Pharmacy also provides food to everyone in the patient’s household, which
allows for an increased likelihood of sustained behavioral change. 45
3. Mom’s Meals (National)
Mom’s Meals is a nation-wide home delivery meal service that provides fully prepared,
refrigerated meals.46 Mom’s Meals allows individuals to select meals from nine different menus

35

Id.
Id.
37 Id.
38 Aubrey, supra note 1.
39 Id.
40 Id.
41 Id.
42 Id.
43 Aubrey, supra note 1.
44 Id.
45 Id.
46 About, Mom’s Meals, https://www.momsmeals.com/about/ (last visited Apr. 29, 2021).
36
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intended for general wellness, lower-sodium diets, heart-friendly diets, diabetes-friendly diets,
renal-friendly diets, and cancer support diets.47 The company’s goal is “to ensure nutrition is
accessible by all, which ultimately leads to better health outcomes.” 48
Mom’s Meals partners with insurance providers, managed care organizations, state
governments, and individuals.49 Mom’s Meals claims that “93% of meal program recipients are
able to continue living in their homes thanks to home delivered meals.”50 Studies conducted by
Mom’s Meals indicate that utilization of their services lead to a reduction in A1C levels and body
mass index, which are used as indicators of obesity, within ninety days.51
4. Operation Food Search’s Fresh Rx (Missouri)
Fresh Rx, which is operated by St. Louis food bank Operation Food Search, provides fresh
food to low-income pregnant women with the aim of improving health outcomes for the mother
and child.52 The program provides food, cooking classes, and nutrition resources. 53 Fresh Rx
offers a meal kit option for patients, including a welcome kit that provides the patient with critical
kitchen tools.54
A pilot study showed a reduced rate of premature births among program participants, which
resulted in an immediate savings of $15,400.55 The program also decreased the number of babies
born underweight, which resulted in $189,100 in healthcare cost savings.56

If these health

outcomes were replicated across the St. Louis Medicaid population, the potential health care cost
Mom’s Meals, https://www.momsmeals.com/ (last visited Apr. 29, 2021).
Mom’s Meals Presence at National Association of Area Agencies on Aging Annual Conference Showcase Out
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Sep.
22,
2020,
https://www.momsmeals.com/news/press-releases/moms-meals-presence-at-n4a-virtual-conference-and-trade-show/
49 Mom’s Meals, https://www.momsmeals.com/ (last visited Apr. 29, 2021).
50 Id.
51
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https://www.momsmeals.com/webres/File/Brochure%20PDFs/CareMore%20Diabetes%20Case%20Study.pdf.
52 Program Overview, Fresh Rx, https://ofsfreshrx.org/program-overview/ (last visited Apr. 29, 2021).
53 Id.
54 Chris Costanzo, Missouri Food Bank Makes a Business Case for Food as Medicine, THE C OUNTER (Nov. 13, 2020)
https://thecounter.org/missouri-food-bank-makes-a-business-case-for-food-as-medicine/.
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47
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savings would be close to six million dollars annually. 57 At scale, Fresh Rx anticipates annual
costs per household between $1,000 and $1,200. 58
III. Limitations of Existing Regulations
The existing regulation of food and healthcare provides an initial framework for food-asmedicine program oversight. Those regulations, however, fail to adequately consider the various
challenges that are associated with the food -as-medicine movement.

Given the number of

regulators that could be involved in the prescription and dispensing of food, there is the potential
for conflicting regulations that span a multitude of different agencies. For example, agencies
responsible for regulating prescribing behavior, agencies responsible for medical prescriber and
dispenser licensing, agencies responsible for nutritionist and dietician licensing, agencies
responsible for the regulation of food, and agencies responsible for the dispensing of drugs could
all potentially be invested and interested in regulating activities in the food -as-medicine
movement. Given the number of stakeholder agencies, there is a high potential for regulations to
become burdensome and conflicting. This section evaluates existing regulations that may be
applicable to the food-as-medicine movement.
A. Prescribing Behavior
Prescribing behavior is strictly regulated.59

Depending on the classification of the

prescribed drug, various state and federal laws may apply. 60 The federal government regulates
prescription drugs through FDA approval and labeling requirements and limitations placed on
prescribing through scheduling of prescription drugs and prescriber registration by the Drug
Enforcement Administration. States may require the use of tamper-resistant prescription pads,

57

Id.
Id.
59 See Valarie Blake, Fighting Prescription Drug Abuse with Federal and State Law , 15 VIRTUAL M ENTOR 5, 443
(2013).
60 Id.
58
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registration of the prescribing physician, or other extensive regulations.61 Because prescription
drugs have the opportunity to be abused or to have negative health effects on third parties to whom
the prescription may be diverted, prescribing physicians are highly regulated.62 The prescription
of food does not present the same concerns because there is little opportunity for a negative health
effect simply because of the food consumption.63 Potential diversion of prescribed food does not
lead to the public health concerns that pertain to the diversion of prescription drugs.
B. Dispensing Activities
Pharmacies also are highly regulated to ensure the security of the drug supply chain, the
safe dispensing of controlled substances, and the safe disposal of hazardous waste. 64 This
regulation is necessary because of the hazards associated with drugs. When dispensing food
products, these concerns do not exist.65 As such, regulations addressing the dispensing of
prescription products do not add significant value to the dispensing activities involved in food-asmedicine products. To the extent possible, the dispensing of food should not fall under regulations
involving the dispensing of drugs.
C. Insurance Reimbursement
Insurance reimbursement policies will be the largest driver in expanding access to food-asmedicine products.66 Food-as-medicine movements also address food insecurity in lower-income
populations and the treatment of chronic diseases; thus, recipients of food-as-medicine programs

61

Id.
Id.
63 Negative health effects are possible due to allergic reactions or foodborne illness; these concerns are outside the
scope of what can be adequately mitigated during the prescription process and are better mitigated through regulations
placed on the dispenser and thorough conversations between prescriber and patient.
64 The “ABCs” of Pharmacy Compliance: FDA, DEA, and EPA, M ODERN H EALTHCARE (Sep. 20. 2018),
https://www.modernhealthcare.com/article/20180920/SPONSORED/180929983/the -abcs-of-pharmacy-compliancefda-dea-and-epa.
65 Though the security of the food supply chain is of critical importance, this is better controlled by effective
management by the manufacturer. FDA requires food facilities to prepare and implement food defense plans to
mitigate against intentional acts of adulteration. Food Defense, FDA, https://www.fda.gov/food/food-defense.
66 Costanzo, supra note 54. As a Director at Operation Food Search said, without insurance reimbursement, “[the
program] is just another program offered to the fortunate few” through grants.
62
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are likely to be Medicare or Medicaid recipients. Food insecurity is more common for individuals
with income levels below 200% of the federal poverty level than those with income levels of at
least 200% of the federal poverty level.67 Among those with income levels below 100% of the
federal poverty level, only 11.5% are food secure.68 Many food-insecure people with chronic
health conditions are insured by Medicaid or Medicare.69 As such, reimbursement under Medicaid
and Medicare programs is important in this context.70
The federal government spends over $91 billion annually to treat Medicare and Medicaid
patients with obesity-related health conditions.71 State programs spend almost $8 billion annually
to treat Medicaid patients with obesity-related health conditions.72 Given the huge expenditure to
treat obesity-related health conditions, Medicaid and Medicare investment in food-as-medicine
programs could dramatically lower the overall annual expenditure to treat these prevalent disease
conditions.
While meals typically are not covered under Medicaid or Medicare, nutrition counseling
may be covered depending on state law.73

Medicare Advantage programs can offer more

expansive coverage.74 Specifically, Medicare Advantage may cover home-delivered meals if: “the
service is: (1) needed due to an illness; (2) consistent with established medical treatment of the
illness; and (3) offered for a short duration.”75

67

Seth A. Berkowitz, Sanjay Basu, James B. Meigs & Hilary K. Seligman, Food Insecurity and Health Care
Expenditures in the United States, 2011-2013, 53 H EALTH SERV. RES. 3, 1600 (2018),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980147/.
68 Id.
69 Ardag Hajinazarian, Legal Interventions for Alleviating Food Insecurity Among Medicaid Populations , 28 ANN.
H EALTH L. ADVANCE DIRECTIVE 101, 101 (2018).
70 Private insurance programs may cover food-as-medicine programs through general wellness programs or through
other benefit coverage. Given the differences in private insurance programs, there is a large opportunity for coverage
of food-as-medicine programs through private insurance.
71 Hajinazarian, supra note 69.
72 Id.
73 Malinda Ellwood et al., FOOD I S M EDICINE : OPPORTUNITIES IN PUBLIC AND PRIVATE H EALTH C ARE FOR
SUPPORTING NUTRITIONAL COUNSELING AND M EDICALLY-TAILORED, H OME-DELIVERED M EALS 12 (2014).
74 Id.
75 Id.
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States can also apply for waivers to cover food-as-medicine products under Medicaid.
Waivers permit states to cover non-traditional Medicaid-funded services, provide targeted
services, or perform other non-covered activities, often for a limited period of time.76 Medicaid
waivers may allow a state to contract directly with a food -as-medicine organization to provide
medically tailored meals.77 For states that aim to provide food-as-medicine products to those
enrolled in Medicaid, waivers provide a mechanism for ensuring reimbursement for medically
tailored meals.
D. Congressional Activity
Congress has taken limited actions to regulate and promote food-as-medicine. Though
these actions are limited and have not yet led to full regulation or utilization of food -as-medicine
programs, Congressional interest in the movement indicates that a regulatory scheme for food -asmedicine may be feasible.
1. Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020
In the 116th Congress, Representative McGovern of Massachusetts introduced the
Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020 with a bipartisan
group of sponsors.78

Though unlikely to become law, this proposed legislation indicates

Congressional interest in evaluating the use and effectiveness of medically tailored meals. The
bill, as introduced, requires the Department of Health and Human Services to conduct a
demonstration program to assess the effects of the provision of medically tailored meals by
hospitals to qualified individuals79 The bill requires that the meal be designed by a registered
dietitian or nutrition professional, improve health outcomes, and lower the cost of care.80

76

Id. at 12.
Id. at 14.
78 H.R. 6774, 116th Cong. (2020).
79 Id.
80 Id.
77
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2. Produce Prescription Program (2018 Farm Bill)
The 2018 Farm Bill included funding for a produce prescription program.81 Specifically,
the legislation included funding for pilot programs organized by non-profits or state/local agencies
to partner with healthcare providers to provide fresh produce to low-income people either suffering
from or at risk of diet-related health conditions.82 The purpose of this law is to allow the
Department of Health and Human Services, which includes FDA and the Centers for Medicare &
Medicaid Services, to evaluate the efficacy of programs that provide food.83
IV. FDA Regulatory Schemes Implicated
The FDA is responsible for ensuring the “safety, efficacy, and security” of drugs, medical
devices, and biological products, as well as the safety of most of the food supply.84 The FDA also
has oversight over cosmetic products and tobacco. 85 The FDA is divided into eight centers, each
of which is charged with regulating a specific product category.86 The Center for Food Safety and
Applied Nutrition (CFSAN) and the Center for Drug Evaluation and Research (CDER) are of
particular importance when considering the regulation of the food -as-medicine movement.
A. Regulation of Food
The FDA could regulate food-as-medicine products identical to traditional food products
under the CFSAN regulatory scheme. This framework is likely the most suitable for the products
as they currently exist; however, CFSAN does not have pre-market approval authority. Moreover,
food products regulated by CFSAN are only permitted to make limited health claims, as expressly
authorized by the FDA, and are not allowed to make claims that foods treat particular diseases,

81

Emily Hennessee, Veggie Rx in the 2018 Farm Bill, Johns Hopkins Center for a Livable Future (2020).
Id.
83 Id.
84 What We Do, FDA, https://www.fda.gov/about-fda/what-we-do (last modified Mar. 28, 2018).
85 Id.
86
History of FDA’s Centers and Offices, FDA, https://www.fda.gov/about-fda/history-fdas-internalorganization/history-fdas-centers-and-offices (last modified Dec. 7, 2017).
82
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except as specifically approved by the FDA, as occurs with food-as-medicine products. The
existing CFSAN framework nonetheless provides an initial baseline regulatory scheme that can be
modified to regulate food-as-medicine products.
1. Food Regulations Generally
Food regulation is heavily reliant on post-market surveillance; pre-market approval by
FDA is limited to food additives.87 FDA’s regulatory authority over food producers is limited.
Food facilities are required to register with FDA, which also vests the FDA with authority to
inspect the facility.88 Facilities must renew their registration every two years. 89
Additionally, all FDA-regulated food facilities must comply with Current Good
Manufacturing Practices (CGMPs) for food.90 CGMPs require that food is not adulterated,
meaning that the food is not “prepared, packed, or held under insanitary conditions” and is not
“contaminated with filth, or . . . rendered injurious to health.” 91

CGMPs include defined

requirements for personnel, the facility’s grounds, processes, design, equipment, cleaning,
production controls, testing, and distribution.92
In addition to CGMPs, food facilities are required to comply with FDA’s product labeling
requirements. Foods with more than one ingredient must include a label that includes all required
components.93 Product labels are required to include: the name of the food; a statement of the net

Is It Really ‘FDA Approved?,’ FDA, https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved (last
modified Jan. 17, 2017).
88 Registration of Food Facilities and Other Submissions, FDA, https://www.fda.gov/food/guidance-regulation-foodand-dietary-supplements/registration-food-facilities-and-other-submissions (last modified Dec. 1, 2020).
89 Id.
90
Current Good Manufacturing Practices (CGMPs) for Food and Dietary Supplements, FDA,
https://www.fda.gov/food/guidance-regulation-food-and-dietary-supplements/current-good-manufacturingpractices-cgmps-food-and-dietary-supplements (last modified Jan. 31, 2020).
91 21 C.F.R. § 110.5.
92 See 21 C.F.R. Part 110.
93 Single-ingredient foods may still be required to be labeling but given the different requirements for single-ingredien t
foods, only multi-ingredient foods are discussed here. Food-as-medicine products will rarely qualify for the single
ingredient labeling exception.
87
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quantity of contents; the name and contact information of the company; an ingredient statement,
including an allergen declaration; and nutrition labeling. 94
FDA’s primary pre-market approval authority for food items is limited to food additives.
Food additives are “[a]ny substance that is reasonably expected to become a component of food.”95
Additives are subject to pre-market approval by FDA unless they are generally recognized as safe
(GRAS).96 Food additives may be GRAS if they were used in food prior to 1958 or there is general
scientific recognition of their safety based on evidence.97
2. Health Claims
Health claims are “any claim made on the label or in labeling of a food . . . [that]
characterizes the relationship of any substance to a disease or health-related condition.”98 Health
claims can be either express or implied.99 FDA permits health claims on foods only in very specific
circumstances.100 “To be approved by the FDA as an authorized health claim, there must be
significant scientific agreement among qualified experts that the claim is supported by the totality
of publicly available scientific evidence for a substance/disease relationship.” 101 FDA authorizes
specific health claims when significant scientific agreement exists.

Currently, there are no

authorized health claims permitted for the treatment of chronic diet-related health conditions.102
Instead, authorized health claims are limited to specific food compounds and a disease state. 103
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When an authorized health claim does not exist, a company may be permitted to make a
qualified health claim. When health claims do not meet the significant scientific agreement
standard, they must be accompanied by a disclaimer that communicates the existing level of
scientific agreement.104
3. Medical Foods
Medical foods are foods specifically designed and prescribed for the management of a
disease or condition when that disease or condition has distinctive nutritional requirements, such
as those caused by nutritional deficiencies. 105 Medical foods are distinct from food-as-medicine
products because food-as-medicine products do not address diseases or conditions with a
distinctive nutritional requirement. The medical foods regulatory scheme provides an insight into
how FDA may regulate the use of foods to address disease and disease conditions. To qualify as
a medical food, the food must: (1) be specially formulated and processed; (2) “intended for the
dietary management of a patient, who . . . has limited or impaired capacity to ingest, digest, absorb,
or metabolize ordinary foodstuffs”; (3) “provide[] nutritional support specifically modified for the
management of the unique nutrient needs that result from the specific disease or condition, as
determined by medical evaluation”; (4) and “[be] intended to be used under medical
supervision.”106 In essence, medical foods are used as part of an ongoing and active medical
treatment plan, through which the patient receives instruction on the food’s use.107
Medical foods may not be labeled as “Rx only”; FDA has removed medical food from this
requirement and defines such products as misbranded if they include an “Rx only” designation.108
Additionally, FDA does not require a prescription for the dispensing of medical food; instead,
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FDA simply mandates that the medical food be consumed under the supervision of a physician.109
“Under the supervision of a physician” is defined broadly as a patient receiving active and ongoing
medical supervision in either inpatient or outpatient format, and does not require the physician’s
active involvement in the consumption of the food.110
4. Dietary Supplements
Dietary supplements are products taken by mouth that contain a “dietary ingredient,” which
include vitamins, minerals, amino acids, or other substances that can be used to supplement the
diet.111 Dietary supplements cannot be represented as a conventional food or drug and , instead,
must be marketed as a supplemental product. 112
Labels on dietary supplements are permitted to make much broader health claims than
those permitted on conventional foods.113 Labels can include health claims that have not been
proved to be true or accurate, though it is not permissible to market a dietary supplement as a
treatment or cure for a specific disease or to mitigate the symptoms of a particular disease.114
Because food-as-medicine programs are conventional foods, they would not be regulated as dietary
supplements. Dietary supplements are permitted to make broader health claims; therefore, some
of the regulations that pertain to dietary supplement health claims may provide useful guidance in
developing rules for food-as-medicine health claims.
5. Limitations of Food Regulations
Existing food regulations could provide a framework for the regulation of food-asmedicine programs. They are, however, an imperfect fit because they would not permit food-as-
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medicine health claims, which is a cornerstone of these products. Food regulations also proscribe
the pre-market approval of products, which would be necessary for effective regulation of foodas-medicine. Finally, FDA’s regulation of food is currently limited to the agency’s resources
devoted to inspections and post-market surveillance.

As discussed below, these limited

surveillance techniques are likely insufficient to reduce the risk to patients using food-as-medicine
programs.
B. Regulation of Drugs
Due to the disease-treatment claims made by food-as-medicine products, they could easily
be regulated as drug products by CDER. The regulatory framework that exists for drugs is likely
too burdensome for food-as-medicine products and would stifle the growth of the movement. That
said, CDER’s regulatory processes provide a basis for approval of products that treat diseases that
could be applied to food-as-medicine products.
1. Drug Regulations Generally
Drugs are products “intended for use in the diagnosis, cure, mitigation, treatment, or
prevention of disease” and “intended to affect the structure or any function of the body.” 115 Drugs
are subject to pre-market approval.116 Prior to approval, drug sponsors are required to submit
scientific evidence to FDA establishing that the product is safe and effective.117
Many of the requirements for drug manufacturers mirror requirements imposed on food
manufacturers, though typically with more robust regulation. Facilities that manufacture, repack,
or relabel drugs must register with FDA. 118 Similar to food products, FDA has the authority to
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inspect drug manufacturing facilities.119 Additionally, drug manufacturers are required to comply
with CGMPs specific to pharmaceutical products. 120 CGMPs provide requirements for the
facility’s design, equipment, product packaging design, personnel, and documented processes,
among other requirements.121
Most importantly, drugs are subject to a rigorous pre-market approval process. This
process begins with a preclinical investigation, which then leads to the submission of an
Investigational New Drug Application (IND) with FDA. 122 After submission of the IND, FDA
reviews the application to determine if the product sponsor can commence clinical trials.123
Clinical trials are used to determine baseline safety of the product, establish the product’s efficacy
against the target disease, and evaluate the product’s safety in a larger population.124 After
significant data is obtained through clinical trials, the manufacturer files a New Drug Application
(NDA) seeking FDA approval to market the drug in the United States.125 To be approved, the
product manufacturer must provide “substantial evidence” that the drug is effective and safe under
the proposed conditions of use.126 FDA’s “substantial evidence” standard demands high quality
and a high quantity of data.127
2. FDA’s Combination Products Regulations
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Combination products are products that are composed of any combination of a drug,
device, or biologic.128 FDA created an Office of Combination Products to facilitate the regulation
of products that would fall within the jurisdiction of two centers at FDA.129 The Office of
Combination Products determines which Center the product will be primarily regulated by based
on the product’s “the primary mode of action.”130 The primary mode of action is the action that
provides the “most important therapeutic action of the combination product.” 131 Although
combination products do not currently include products that are both drug and food, an opportunity
exists to create a new definition of a food-drug combination that would encompass food-asmedicine products.
3. Limitations of Drug Regulations
Drugs are highly regulated and, thus, demand a much larger investment of time and money
than food products. 132 As such, regulating food-as-medicine products as drugs may force current
and potential providers out of the market due to those resource requirements. Similarly, the drug
approval process requires substantial clinical trials that may not be feasible for many food -asmedicine providers.
V. Regulatory Proposal to Address Limitations of FDA Regulation
While a comprehensive regulatory scheme is necessary to ensure effective control of foodas-medicine programs and products, regulation can and should be implemented in stages. Initial
regulation should address the immediate concerns with the movement. Once initial regulations
are in place, FDA can develop and implement a more comprehensive scheme.

128

Frequently Asked Questions About Combination Products, FDA, https://www.fda.gov/combinationproducts/about-combination-products/frequently-asked-questions-about-combination-products (last modified Apr. 9,
2020).
129 Id.
130 Id.
131 21 C.F.R. §3.2(m).
132 Fact Sheet: FDA at a Glance, FDA, https://www.fda.gov/about-fda/fda-basics/fact-sheet-fda-glance (last modified
Nov. 18, 2020).

21

A. Immediate Needs
Congress’s initial step should be to grant FDA the authority to evaluate food-as-medicine
products for efficacy and safety. Congress should extend to FDA exclusive authority to regulate
food-as-medicine products and not create an overlapping jurisdictional scheme that involves
United States Department of Agriculture (USDA) regulation. Once Congress grants the agency
such powers, FDA can effectively manage the risks posed by the food -as-medicine movement.
FDA then can and should conduct pre-market approval of food-as-medicine products, evaluating
product efficacy and safety. These initial grants of regulatory authority would only address
immediate concerns and would not regulate food-as-medicine in a manner that would permit
continued growth of the movement.
1. Efficacy
FDA ensures the efficacy of drug and device products, though no similar requirement exists
for food products. Given that food-as-medicine products make health claims regarding their ability
to treat and mitigate particular diseases or health conditions, these products must be evaluated for
efficacy.
The food-as-medicine movement is more likely to expand and succeed if FDA requires
product producers to demonstrate pre-market efficacy. Following FDA approval of the health
claims made by food-as-medicine products, prescribers are more likely to prescribe these products
to food insecure patients because the product has been validated by FDA. A demonstration of
efficacy is also likely to increase insurer willingness to cover the costs of these programs. As in
the drug and device pre-market approval processes, FDA should require “substantial evidence” of
the effectiveness of the diet or product. 133 The “substantial evidence” threshold may prevent food-

“Substantial evidence” in the drug and device context requires, typically, high quality data as well as a large quantity
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as-medicine companies from adequately demonstrating effectiveness because of the difficulty in
conducting studies on human nutrition.134 For example, clinical nutrition research must take into
account individual differences in metabolism, dietary habits, and initial nutritive profiles. It is also
difficult to create a true double-blind study in this context.135 Given these challenges, the
“substantial evidence” standard should be modified to accommodate these challenges.
FDA should create an internal task force made up of individuals from the Center for Drug
Evaluation and Research (CDER) and the Center for Food Safety and Applied Nutrition (CFSAN)
to review efficacy studies submitted by food-as-medicine companies. CDER members are highly
trained at evaluating efficacy data, while CFSAN members will be able to assist in evaluating the
data while considering the challenges unique to nutrition studies. Once the task force has
determined that adequate efficacy data has been submitted, the claim should be approved for use
by the dispenser who submitted the data. FDA should permit food-as-medicine dispensers the
right to seek universal approval for the claim in question, which would allow other dispensers to
utilize the same claim so long as their product satisfies the same nutritional parameters. Though a
cross-functional task force will be created to review efficacy data, post-market authority to regulate
food-as-medicine products would remain fully within CFSAN following initial product approval.
Given the cost and time associated with conducting clinical trials, FDA also should review
existing nutrition studies to create approved health claims that can be used by any food -asmedicine provider. When a product meets the nutritional requirements identified by FDA, the
agency ought to approve that product for the treatment of the particular health condition or disease.
FDA has already approved several health claims related to the prevention of diseases or health

134

Though human nutrition studies are difficult to conduct, as food -as-medicine companies conduct studies on
efficacy, it is likely that food-as-medicine patients may provide a less complex set of data because the patient would,
ideally, be only consuming the products prescribed and provided through the food -as-medicine program.
135 Connie M. Weaver & Joshua W. Miller, Challenges in Conducting Clinical Nutrition Research , 75 NUTR. R EV.
491 (2017), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654371/ (discussing many of the challenges unique to
human nutrition studies).

23

conditions.136 FDA can expand these approved health claims by reviewing existing clinical
nutrition studies and determining where evidence establishes that a change in diet can effectively
treat a disease or health condition.137 Once FDA creates a list of approved health claims, food-asmedicine companies simply need to demonstrate that the product meets the defined nutritional
criteria for the claim, rather than establishing effectiveness. FDA should require a demonstration
of equivalence from the food-as-medicine provider to permit the nutrition claim similar to the
process the agency uses to approve generic drugs.138
2. Food Safety
In addition to ensuring the efficacy of food-as-medicine products, FDA must ensure their
safety. Foodborne illness affects approximately one in every six people each year and 3,000 people
die annually from these diseases in the United States.139 Individuals with chronic health conditions
are at heightened risk for foodborne illness.
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Many of the chronic diseases targeted by food-as-

medicine programs (e.g., cancer, HIV/AIDS, diabetes) enhance the risk of foodborne illness.
These foodborne illnesses can have a more devastating impact on those with underlying chronic
health conditions.141
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As such, FDA must increase safety evaluations of dispenser facilities and practices.
Additionally, FDA must review the dispenser’s food safety plan prior to its approval of the
dispenser’s product. Food safety plans for dispensers should include an evaluation of all potential
risks associated with the ingredients of the product and the processing steps, including any risk
that may be introduced or exacerbated by the patient while handling the product at home. For each
significant risk identified, the dispenser must identify and implement a control to reduce the risk.142
3. USDA Implications
USDA’s Food Safety and Inspection Service (FSIS) is responsible for ensuring that meat,
poultry, and processed eggs sold within the United States are safe and properly labeled. 143 Many
food products include both USDA and FDA regulated components.144 Some food-as-medicine
products are likely to fall under USDA’s jurisdiction due to product composition.
When FDA needs to address issues that may cause conflict with other entities, including
other agencies within the federal government, the agency enters into Memoranda of Understanding
(MOUs) to create a non-binding understanding between the agencies. 145 FDA executes MOUs
when there is a need to define or clarify responsibilities between agencies to eliminate duplicative
actions.146
Given that certain food-as-medicine products could be subject to USDA regulation, FDA
and USDA should enter into an MOU in which USDA cedes regulatory authority over any foodas-medicine product to FDA. The MOU should indicate that FDA will independently regulate
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food-as-medicine products that would otherwise be regulated by USDA. However, the MOU
should require that all USDA-regulated components of the product be produced in a USDAinspected facility.147
B. Regulatory Needs Following Initial Implementation
Although the framework discussed above describes an initial regulatory scheme for foodas-medicine products, it is limited to FDA evaluation of product safety and efficacy and does not
encourage continued expansion of the food-as-medicine movement.

Because the food-as-

medicine movement has the potential to dramatically improve the health of individuals with
chronic conditions, the regulatory scheme should be designed to encourage continued growth and
utilization of prescription food.
1. Efficacy
FDA and other federal agencies should create grant programs to evaluate the efficacy of
each food-as-medicine dispensing model and food type. As nutrition data improves, it will become
feasible for FDA to approve additional health claims. When increased data supporting the efficacy
of food-as-medicine products is available, insurers are increasingly likely to cover the dispensing
of food and physicians are increasingly likely to prescribe food-as-medicine products. The initial
grants should be awarded to study the effectiveness of various food-as-medicine programs; the
second wave of grants ought to be devoted to the expansion of nutrition research on food-asmedicine products.148
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2. Food Safety
Regarding the safety of food-as-medicine programs, FDA must increase its post-market
surveillance of dispensers. This may include careful evaluation of food safety complaints, as well
as increased inspections of dispensing locations. Many FDA-regulated facilities are inspected
infrequently, with less than one-quarter of facilities inspected annually.149 In 2010, the Office of
Inspector General found that many facilities had not been inspected in five or more years. 150 While
FDA conducts inspections based on the risk categorization of the facility,151 FDA must inspect
food-as-medicine facilities at least annually. Food-as-medicine dispensaries must be considered
high-risk given the additional complicating effect of foodborne illness on the chronic health
conditions these products intend to treat.
FDA only has the authority to inspect and regulate facilities that are distributing products
into interstate commerce.

Many dispensing models will operate fully within one state (or,

potentially, an even smaller geographic radius), preempting federal regulation by FDA. The Food,
Drug, and Cosmetic Act, which grants FDA the authority to regulate food products, was enacted
based on Congress’s ability to regulate interstate commerce under the Commerce Clause. 152 To
effectively regulate all aspects of the food-as-medicine movement, FDA must have regulatory
power over local, non-interstate dispensing locations in addition to interstate operations. Likely,
FDA will need to enter into MOUs with local and state regulatory agencies to either grant FDA
authority to regulate on behalf of the local agency or empower the local agency to regulate under
FDA guidelines. Currently, FDA partners with many local regulatory agencies to enforce FDA
policies, where the local agency contracts with FDA to conduct an inspection to determine
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compliance with FDA regulations.153 As of 2020, forty-three states participate in the Human Food
Inspection Contract Program, which functions as FDA’s local partnership program.154

By

expanding the Contract Program to food-as-medicine dispensaries, FDA policies could continue
to impact local, intrastate dispensaries as well as interstate facilities.
C. Resources
Although increased regulation and oversight by FDA will require resource investment, the
expansion of the food-as-medicine movement has the potential to dramatically reduce national
expenditure on health care for chronic health conditions and diseases. Caring for chronically ill
populations costs the American economy more than $1 trillion annually.155 The economic burden
of diabetes alone was estimated at almost $404 billion in the United States in 2017, with an average
economic burden per diabetic individual of over $13,000.156 These programs have proved to
reduce healthcare costs up to $10,000 per month per patient.157 Participation in a food-as-medicine
program reduces inpatient admissions, length of stay for inpatient admissions, and costs for
inpatient admissions.158 Food insecure households spend forty–five percent more on medical care
than those in food-secure households.159 By reducing food insecurity and treating chronic health
conditions through diet changes, the country can dramatically reduce the cost of healthcare.
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Investment to empower FDA to adequately regulate food-as-medicine programs will create
reductions in national healthcare expenditures. These savings can then be reinvested in regulatory
efforts to enhance the safety and efficacy of food-as-medicine products, which will likely lead to
increased utilization and prescription of food-as-medicine programs. As this cyclical process
begins, an immediate investment in FDA regulation is necessary; however, as the cycle continues,
the initial investment will be returned to the federal economy through the reduction of healthcare
costs associated with treating chronic diseases.
D. Public Policy Considerations
Regulation of the food-as-medicine movement requires careful consideration of policy
implications. The food-as-medicine movement should be encouraged because of its positive health
impacts; as such, regulations should be implemented to allow the movement to reach its full
potential. First and because there are no possible negative health effects160 if someone other than
the prescribed patient consumes the food, prescriptions should be widely available and not limited
based on the possibility that the patient will not consume the food or it will be diverted. A third
party that receives prescribed food will face no negative effects as might occur with prescription
drugs.
Second, regulations should allow for the prescription and reimbursement of medically
tailored foods and meals for entire families. When an entire household is food insecure and atrisk for chronic diseases, early intervention is more impactful than later attempts to change
behavior and health outcomes. Moreover, patients are more likely to commit to changing eating
and diet behavior with community support.
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Finally, providers of food-as-medicine programs should be encouraged to develop
programs that sustainably maintain the health benefits obtained through the programs. A pyramid
of food-as-medicine approaches has been proposed. This pyramid suggests that patients should
be placed in different programs based on their individual health needs and social determinants of
health.161 The pyramid proposes that medically tailored meals be used for the seriously or
chronically ill and the disabled.162 Prescription medically tailored food should be utilized by
patients who are chronically ill but are more mobile and have less severe symptoms. 163 Prescribed
medically tailored food also should be utilized for those who are at risk of a chronic illness due to
health indicators.164 Prescribed food, without diet restrictions, on the other hand, should be
provided to those who are food insecure but are not currently suffering from chronic health
conditions.165 As used in drug prescription schemes, patients should be placed on the lowest level
of prescription for their needs; the food-as-medicine regulatory scheme must incorporate
incentives for prescribers and dispensers to only prescribe the food that is necessary for the patient
while still providing easy access to and reimbursement for the prescribed foods.
VI. Conclusion
The food-as-medicine movement provides a systemic way to address the heavy health
burden faced by the food insecure. Without effective regulatory oversight, the food-as-medicine
movement has the potential to be underutilized and abused. With effective regulation and
reduction in barriers to utilization, the movement is more likely to grow in size, scope, and success.
The regulatory scheme must begin with FDA, be cohesive, and be flexible enough to allow other
regulatory bodies to build on the initial regulatory scheme. Food-as-medicine programs can
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address systemic food insecurity and chronic health conditions, but a comprehensive regulatory
scheme must be established to allow these programs to fulfill their full potential.

31

